Your ultimate cannabis investing Q&A replay is ready…

I love being able to connect with you directly. And part of that is talking with you one-on-one in our live video sessions.

In our latest live Q&A last Thursday (I plan on making these much more frequent), you kept me on my toes, with great questions pouring in even past the one-hour mark.

Thank you to all those who were able to attend!

Now, I know many of you might not have been able to tune in live, could only catch the beginning, or didn’t get the chance to have your question answered.

So, as promised, I’m sharing the full replay of what might’ve been our biggest live cannabis investing Q&A session yet.

From the best public companies to own right now to startups that let you invest before an IPO, we covered every single way for you to make money.

And we showed you how to take advantage of the incredible opportunities that lie ahead of you…

Your Ultimate Cannabis Investing Q&A Replay Is Ready

During Thursday’s cannabis investing Q&A, I gave you the inside track to over a dozen of your favorite cannabis companies and revealed which of them are the best and worst stocks to own right now, including:

  • Aleafia (OTC: ALEAF)
  • Charlotte’s Web Holdings Inc. (OTC: CWBHF)
  • Cardiol Therapeutics (OTC: CRTPF)
  • Trulieve Cannabis Corp. (OTC: TCNNF)
  • GW Pharmaceuticals (Nasdaq: GWPH)
  • MedMen Enterprises Inc. (OTC: MMNFF)
  • Vireo Health International Inc. (OTC: VREOF)
  • Plus Products Inc. (OTC: PLPRF)
  • Curaleaf Holdings Inc. (OTC: CURLF)

I even shared a brand-new Reg CF startup investing opportunity available only to NICI Membership subscribers and a few exclusive updates on past and present private deals in the Cannabis Venture Syndicate pipeline.

Editor’s Note: In just a few short days, your opportunity to own a piece of one of Las Vegas‘s largest cannabis operators for only $1 per share ends. It’s a rare private deal you can’t afford to miss, with this startup’s planned cannabis resort on the Strip potentially setting its early investors up for gains as high as 9,000%. Click here to get all the details on this Cannabis Venture Syndicate deal before it closes for good.

This is information you won’t find anywhere else – and we’ve got the full replay for you right here:

I know I wasn’t able to answer every single one of your questions, so please post them in the comments below, and I’ll make sure you get the answers you need.

Otherwise, we’ll be hosting another of these live Q&As in the coming months. I look forward to taking your questions then!

Take care,

Don Yocham
Executive Director, National Institute for Cannabis Investors


39 responses to “25 Answers to 25 Questions That Will Help You Get the Most Out of Cannabis Investing”

    • Hi Kelly,

      Don believes cbdMD is an okay player in the CBD space, but there are more opportunities in investing in multi-state operators (MSOs) right now.

  1. 1. What the difference between the existing Emerald Health and new pre-IPO Emerald Health? 2. Cannabis Venture – do you always go thru the Dealmaker company? 3. How do you determine when to sell?

  2. Hi Don. I sent in a lengthy question to the wrong spot- Venture Syndicate Mastermind New Subject. Can you please address these questions either here or in a written format for the group? Thanks so much.
    David Berna.

    • Hi Bob,

      Don believes that iAnthus is a lost cause. He highlights some of the companies he is most excited about in the webinar Q&A.

  3. I have decided to buy $1000 of MSOS ETF shares with the intention to buy even more. This is the first USA ETF that includes plant touching companies in the US. What is your short and long term opinion concerning this ETF, thanks.

    • Hi Donald,

      Don mentioned in the webinar that ETFs aren’t a bad place to get started, and MSOS has some good companies in its holdings. But instead of owning a lot of different cannabis stocks, it’s better to be selective and focus on the best of the best. That is where the most money will be made.

  4. Hi Don, I purchased quite a few shares in Fire and Flower and was wondering what you thought the outlook for Fire and Flower might be.

    • Hi Mike,

      Don believes that the stake in Canopy is really starting to sting, and Acreage has its own issues as it has cancelled an acquisition, sold assets, temporary closed some facilities, and furloughed workers since April. He does not believe STZ is a buy at this point.

  5. Hi Don
    Would it be possible to start issuing target prices on your recommendations so the members can get a better feel of the potential upside of each stock?
    Lawrence Taylor

    • Hi Sam,

      We have TRTC as one of the lowest-rated companies in our database. With financing issues and a history of lawsuits, there are better choices out there.

  6. Hello,
    Clever Leaves is doing a reverse merger with Schultze Special Purpose Acquistion. Noticed you have them listed on NICI chart but there is no rating for the company. Do you think Clever Leaves is a good investment?

  7. Hi there, do you have any opinion on High Times and its supposedly upcoming IPO? I invested money in their Reg A+ offering, and I’m becoming very concerned about all the failed acquisitions, etc. Adam Levin seems to not be the right guy for the job, and the following article really slams that home. Did I make a big mistake? I suppose I’m stuck either way. Would really appreciate your input on this. Thanks.

  8. Hi Don”. At looking at Plus Products and their New Sleep brand of gummies , is it a definite out look to be moving on from them without the possibility of a quick rebound in the very near future for them?

  9. Hi Don what is your thoughts on ycbd, I got in on it at 1.08 do u think it has anymore room to grow or is it time to let go. Thanks

Leave a Reply

Your email address will not be published. Required fields are marked *